β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
Open Access
- 13 December 2011
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 20 (6), 741-754
- https://doi.org/10.1016/j.ccr.2011.10.030
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationThe New England Journal of Medicine, 2011
- Peptidyl-prolyl Cis/Trans Isomerase NIMA-interacting 1 Associates with Insulin Receptor Substrate-1 and Enhances Insulin Actions and AdipogenesisOnline Journal of Public Health Informatics, 2011
- mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptideThe EMBO Journal, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylationOncogene, 2009
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelProceedings of the National Academy of Sciences of the United States of America, 2009
- Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young AdultsJournal of Investigative Dermatology, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005